Eye Abnormalities
13
1
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (13)
Modeling Ocular Developmental Diseases From 3D Cultures of Optic Vesicle Organoids Derived From hiPSCs of Patients With Ocular Malformations
The Heidelberg Engineering BI US Evaluation Study
Agreement and Precision Study
Effects of a Combination of Polyphenol-rich Extracts on the Protection of Retinal Cells Against Blue Light in the Prevention of Ocular Diseases
Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)
Reading Problems Associated With Central Nervous System (CNS) Pathologies.
The Heidelberg Engineering ANTERION Imaging Agreement Study
Eye and Growth in Adolescents Born Moderate-to-late Preterm
International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy
Relation Between Oculocardiac Reflex and Laryngospasm
Independent Prescribing Optometrists in Acute Ophthalmic Services
The Stroke Vision App: A Screening Tool for Visual Stroke
Epidemiological Profile of Ophthalmological Care in the Public Service in Brazil